Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Kunal Rai, Emily Z. Keung et al.|Cell Reports|2020Cited by 70
A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal TumorsWei Zhang, Susanne Hipp, Paul J. Adam et al.|Clinical Cancer Research|2022Cited by 20
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Kunal Rai, Emily Z. Keung et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 8
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant MelanomaMayinuer Maitituoheti, Kunal Rai, Emily Z. Keung et al.|SSRN Electronic Journal|2020Cited by 2
Data from A Novel B7-H6–Targeted IgG-Like T Cell–Engaging Antibody for the Treatment of Gastrointestinal TumorsWei Zhang, Susanne Hipp, Aurélie Auguste et al.|Unknown|2023Cited by 0